Literature DB >> 8760384

Regulation of beta-adrenoceptor density and mRNA levels in the rat heart cell-line H9c2.

V Dangel1, J Giray, D Ratge, H Wisser.   

Abstract

The regulation of the expression of beta-adrenoceptor (beta-ARs) is not thoroughly understood. We demonstrate that the rat heart cell-line H9c2 expresses both beta 1- and beta 2-ARs. In radioligand-binding experiments, the maximal binding capacity of (-)-[125I]-iodocyanopindolol was determined as 18 +/- 0.6 fmol/mg of protein with a KD of 35.4 +/- 4.1 pM. Competitive radioligand-binding experiments with subtype-specific beta-antagonists reveal a subtype ratio of beta 1- to beta 2-ARs of 29%: 71%. With competitive reverse-transcriptase PCR we found beta 2-mRNA to be up to 1600 times more frequent than beta 1-mRNA. Treatment of the H9c2 cell-line with the beta-adrenergic agonist (-)-isoproterenol (10(-6) M), the antagonist (-)-propranolol (10(-6) M) and the glucocorticoid dexamethasone (500 nM) induces regulatory effects on both the beta-AR protein and mRNA level. Isoproterenol treatment leads to down-regulation of the total receptor number by 56 +/- 4%, due to a decrease in beta 2-ARs, while maintaining the beta 1-AR number constant. On the transcription level, both beta 1-and beta 2-mRNAs are decreased by 30% and 42% respectively. mRNA stability measurements reveal a reduced half-life of beta 2-mRNA from 9.3 h to 6.5 h after isoproterenol treatment. Incubation of cells with (-)-propranolol does not affect the amounts of beta-ARs and their mRNAs. Dexamethasone induces a 1.8 +/- 0.2-fold increase in beta-AR number over the basal level as well as a 1.9 +/- 0.2-fold increase in the amount of beta 2-mRNA. Because the half-life of beta 2-mRNA was unaffected by dexamethasone, the increased beta 2-mRNA level must be due to an enhanced transcription rate. The beta 1-mRNA levels are unchanged during dexamethasone-incubation of the cells. Our data clearly demonstrate that treatment of H9c2 rat heart cells with isoproterenol and dexamethasone induces alterations in the level of RNA stability as well as gene transcription, leading to altered receptor numbers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760384      PMCID: PMC1217574          DOI: 10.1042/bj3170925

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

Review 1.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.

Authors:  O E Brodde
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Elevated beta-adrenergic receptor number after chronic propranolol treatment.

Authors:  G Glaubiger; R J Lefkowitz
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

3.  Properties of a clonal muscle cell line from rat heart.

Authors:  B W Kimes; B L Brandt
Journal:  Exp Cell Res       Date:  1976-03-15       Impact factor: 3.905

4.  Presence of both beta1- and beta2-adrenergic receptors in a single cell type.

Authors:  V Homburger; M Lucas; E Rosenbaum; G Vassent; J Bockaert
Journal:  Mol Pharmacol       Date:  1981-11       Impact factor: 4.436

5.  Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.

Authors:  R D Aarons; A S Nies; J Gal; L R Hegstrand; P B Molinoff
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

6.  Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY).

Authors:  M Becker-André; K Hahlbrock
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

7.  Beta 1- and beta 2-adrenergic receptor expression in differentiating 3T3-L1 cells. Independent regulation at the level of mRNA.

Authors:  S J Guest; J R Hadcock; D C Watkins; C C Malbon
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

8.  Agonist regulation of beta-adrenergic receptor mRNA. Analysis in S49 mouse lymphoma mutants.

Authors:  J R Hadcock; M Ros; C C Malbon
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

9.  Agonist-induced destabilization of beta-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of beta-adrenergic receptors.

Authors:  J R Hadcock; H Y Wang; C C Malbon
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

10.  Differential regulation of beta 1- and beta 2-adrenergic receptor protein and mRNA levels by glucocorticoids during 3T3-F442A adipose differentiation.

Authors:  B Fève; L J Emorine; M M Briend-Sutren; F Lasnier; A D Strosberg; J Pairault
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

View more
  9 in total

1.  β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone.

Authors:  Yun Ma; Jeffry S Nyman; Huan Tao; Heather H Moss; Xiangli Yang; Florent Elefteriou
Journal:  Endocrinology       Date:  2011-01-25       Impact factor: 4.736

2.  The effects of hydrocortisone on rat heart muscarinic and adrenergic alpha 1, beta 1 and beta 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling.

Authors:  Jaromír Myslivecek; Jan Rícný; Frantisek Kolár; Stanislav Tucek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-17       Impact factor: 3.000

3.  Effects of dexamethasone on the expression of beta(1)-, beta (2)- and beta (3)-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats.

Authors:  Fuuun Kawano; Jun Tanihata; Shogo Sato; Sachiko Nomura; Akira Shiraishi; Kaoru Tachiyashiki; Kazuhiko Imaizumi
Journal:  J Physiol Sci       Date:  2009-07-08       Impact factor: 2.781

4.  Beta-adrenergic receptor mediated protection against doxorubicin-induced apoptosis in cardiomyocytes: the impact of high ambient glucose.

Authors:  Naohiro Yano; Daisuke Suzuki; Masayuki Endoh; Andy Tseng; Joan P Stabila; Bethany G McGonnigal; Ting C Zhao; James F Padbury; Yi-Tang Tseng
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

5.  Pathological hypertrophy reverses β2-adrenergic receptor-induced angiogenesis in mouse heart.

Authors:  Qi Xu; Nicole L Jennings; Kenneth Sim; Lisa Chang; Xiao-Ming Gao; Helen Kiriazis; Ying Ying Lee; My-Nhan Nguyen; Elizabeth A Woodcock; You-Yi Zhang; Assam El-Osta; Anthony M Dart; Xiao-Jun Du
Journal:  Physiol Rep       Date:  2015-03

6.  Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR.

Authors:  Qian Yin; Chengzhi Yang; Jimin Wu; Haiyan Lu; Xiaohui Zheng; Youyi Zhang; Zhizhen Lv; Xiaopu Zheng; Zijian Li
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

7.  Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation.

Authors:  Rukhsana Gul; Dae-Ryoung Park; Asif Iqbal Shawl; Soo-Yeul Im; Tae-Sik Nam; Sun-Hwa Lee; Jae-Ki Ko; Kyu Yoon Jang; Donghee Kim; Uh-Hyun Kim
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

Review 8.  What is the identity of fibroblast-pneumocyte factor?

Authors:  George King; Megan E Smith; Max H Cake; Heber C Nielsen
Journal:  Pediatr Res       Date:  2016-08-08       Impact factor: 3.756

9.  β-blockers Reverse Agonist-Induced β2-AR Downregulation Regardless of Their Signaling Profile.

Authors:  Sonia Maccari; Vanessa Vezzi; Federica Barbagallo; Tonino Stati; Barbara Ascione; Maria Cristina Grò; Liviana Catalano; Giuseppe Marano; Paola Matarrese; Caterina Ambrosio; Paola Molinari
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.